KEGG   DRUG: D03245Help
Entry
D03245                      Drug                                   

Name
Nartograstim (genetical recombination) (JP16);
Nartograstim (INN)
Formula
C850H1344N226O245S8
Exact mass
18893.7422
Mol weight
18905.6536
Sequence
MAPTYRASSL PQSFLLKSLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
QMEELGMAPA LQPTQGAMPA FASAFQRRAG GVLVASHLQS FLEVSYRVLR HLAQP
(disulfide bridges: 37-43, 65-75)
  Type
Peptide
Activity
Hematopoietic stimulant [DS:H00100]
Remark
Therapeutic category: 
Comment
recombinant G-CSF [HSA:1440] [KO:K05423]
Target
granulocyte colony stimulating factor (G-CSF) receptor agonist [HSA:1441] [KO:K05061]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  Jak-STAT signaling pathway  
 
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  33  Blood and body fluid agents
   339  Miscellaneous
    3399  Others
     D03245  Nartograstim (genetical recombination) (JP16); Nartograstim (INN)
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  Class I cytokine receptors (hematopoietin family receptors)
   granulocyte colony stimulating factor (G-CSF) receptor [HSA:1441] [KO:K05061]
    Nartograstim
     D03245  Nartograstim (genetical recombination) (JAN); Nartograstim (INN)
BRITE hierarchy
Other DBs
CAS: 
134088-74-7
PubChem: 
NIKKAJI: 

» Japanese version   » Back

DBGET integrated database retrieval system